Production (Stage)
InspireMD, Inc.
NSPR
$2.53
$0.2510.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.49% | 12.96% | 24.70% | 22.86% | 23.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.49% | 12.96% | 24.70% | 22.86% | 23.91% |
| Cost of Revenue | 16.21% | 25.13% | 32.97% | 27.67% | 23.11% |
| Gross Profit | -12.75% | -16.66% | 2.80% | 9.66% | 26.17% |
| SG&A Expenses | 39.96% | 42.80% | 41.25% | 45.11% | 42.79% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 45.42% | 48.14% | 42.83% | 37.02% | 28.60% |
| Operating Income | -55.32% | -58.46% | -47.72% | -40.95% | -29.92% |
| Income Before Tax | -59.46% | -60.93% | -45.75% | -36.30% | -24.07% |
| Income Tax Expenses | -9.23% | -9.23% | 132.14% | 132.14% | 132.14% |
| Earnings from Continuing Operations | -59.26% | -60.70% | -45.88% | -36.44% | -24.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.26% | -60.70% | -45.88% | -36.44% | -24.23% |
| EBIT | -55.32% | -58.46% | -47.72% | -40.95% | -29.92% |
| EBITDA | -55.62% | -58.88% | -48.05% | -41.22% | -30.01% |
| EPS Basic | -4.61% | 28.10% | 50.76% | 62.06% | 66.99% |
| Normalized Basic EPS | -4.00% | 28.90% | 51.40% | 62.59% | 67.44% |
| EPS Diluted | -4.61% | 28.37% | 50.89% | 62.14% | 67.05% |
| Normalized Diluted EPS | -4.00% | 28.90% | 51.40% | 62.59% | 67.44% |
| Average Basic Shares Outstanding | 48.97% | 72.95% | 113.69% | 205.80% | 286.89% |
| Average Diluted Shares Outstanding | 48.97% | 72.95% | 113.69% | 205.80% | 286.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |